title: Docosahexaenoic acid reduces haloperidol-induced dyskinesias in mice: involvement of Nur77 and retinoid receptors.
authors.affiliation: Neuroscience Unit, CHUL Research Center, Quebec, Canada.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ethier
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kagechika
authors.forename: Koichi
authors.initials: K
authors.lastname: Shudo
authors.forename: Claude
authors.initials: C
authors.lastname: Rouillard
authors.forename: Daniel
authors.initials: D
authors.lastname: Lévesque
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D014150:Antipsychotic Agents; D001565:Benzoates / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000172:deficiency / Q000502:physiology*; D004195:Disease Models, Animal; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D004409:Dyskinesia, Drug-Induced / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D005786:Gene Expression Regulation / Q000187:drug effects; D020022:Genetic Predisposition to Disease; D006220:Haloperidol; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D017072:Neostriatum / Q000187:drug effects*; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D018160:Receptors, Cytoplasmic and Nuclear; D011987:Receptors, Steroid; D047488:Retinoid X Receptors / Q000819:agonists / Q000037:antagonists & inhibitors / Q000502:physiology*; D014157:Transcription Factors / Q000172:deficiency / Q000502:physiology*
chemical_list: D014150:Antipsychotic Agents; D001565:Benzoates; D001713:Biphenyl Compounds; D004268:DNA-Binding Proteins; C539818:Nr4a1 protein, mouse; D057105:Nuclear Receptor Subfamily 4, Group A, Member 1; D018160:Receptors, Cytoplasmic and Nuclear; D011987:Receptors, Steroid; D047488:Retinoid X Receptors; D014157:Transcription Factors; C438269:diazepinylbenzoic acid; D004281:Docosahexaenoic Acids; D006220:Haloperidol